1. Home
  2. The Medical News
  3. FDA approves new oral drug to treat relapsing forms of multiple sclerosis

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

March 30, 2019
The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

Subscribe via Email

Related Post

0 Response to "FDA approves new oral drug to treat relapsing forms of multiple sclerosis"

Post a Comment

Subscribe to: Post Comments (Atom)